TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Grey Wolf Animal Health Corp ( (TSE:WOLF) ) just unveiled an update.
Grey Wolf Animal Health Corp reported a strong financial performance for the second quarter of 2025, with revenue increasing by 32.3% year over year to $9.5 million and a 56.8% rise in adjusted EBITDA to $2.2 million. The growth was driven by the pharmacy business, which saw a significant increase in sales due to the acquisition of the Compounding Pharmacy of Manitoba and organic growth. The Animal Health business experienced modest growth, with a slight increase in sales of gastrointestinal and behavior products. Despite increased expenses, the company’s gross profit margins improved, highlighting operational efficiency gains.
More about Grey Wolf Animal Health Corp
Grey Wolf Animal Health Corp is a Canadian diversified health company that operates in the animal health industry. The company focuses on providing pharmaceutical products and services, with a significant emphasis on its pharmacy business, which includes compounded products.
Average Trading Volume: 18,831
Technical Sentiment Signal: Buy
Current Market Cap: C$36.93M
For detailed information about WOLF stock, go to TipRanks’ Stock Analysis page.